Size | Price | Stock | Qty |
---|---|---|---|
1g |
|
||
2g |
|
||
5g |
|
||
10g |
|
||
Other Sizes |
|
Targets |
Antibiotic, Bacterial
|
---|---|
References | |
Additional Infomation |
Clindamycin Phosphate is the phosphate salt form of clindamycin, a semi-synthetic, chlorinated broad spectrum antibiotic produced by chemical modification of lincomycin. Clindamycin phosphate is used in topical preparations.
See also: Clindamycin (has active moiety); Benzoyl Peroxide; Clindamycin Phosphate (component of); Clindamycin phosphate; tretinoin (component of) ... View More ... |
Molecular Formula |
C18H34CLN2O8PS
|
---|---|
Molecular Weight |
504.95
|
Exact Mass |
504.146
|
Elemental Analysis |
C, 42.81; H, 6.79; Cl, 7.02; N, 5.55; O, 25.35; P, 6.13; S, 6.35
|
CAS # |
24729-96-2
|
Related CAS # |
Clindamycin hydrochloride;21462-39-5;Clindamycin palmitate hydrochloride;25507-04-4;Clindamycin;18323-44-9;Clindamycin phosphate hydrochloride;64023-51-4
|
PubChem CID |
443385
|
Appearance |
White to off-white solid powder.
|
Density |
1.4±0.1 g/cm3
|
Boiling Point |
159°C
|
Melting Point |
114ºC
|
Index of Refraction |
1.577
|
LogP |
0.93
|
Hydrogen Bond Donor Count |
5
|
Hydrogen Bond Acceptor Count |
10
|
Rotatable Bond Count |
9
|
Heavy Atom Count |
31
|
Complexity |
658
|
Defined Atom Stereocenter Count |
9
|
SMILES |
Cl[C@@]([H])(C([H])([H])[H])[C@]([H])([C@]1([H])[C@@]([H])([C@@]([H])([C@]([H])([C@]([H])(O1)SC([H])([H])[H])OP(=O)(O[H])O[H])O[H])O[H])N([H])C([C@]1([H])C([H])([H])[C@@]([H])(C([H])([H])C([H])([H])C([H])([H])[H])C([H])([H])N1C([H])([H])[H])=O
|
InChi Key |
UFUVLHLTWXBHGZ-MGZQPHGTSA-N
|
InChi Code |
InChI=1S/C18H34ClN2O8PS/c1-5-6-10-7-11(21(3)8-10)17(24)20-12(9(2)19)15-13(22)14(23)16(18(28-15)31-4)29-30(25,26)27/h9-16,18,22-23H,5-8H2,1-4H3,(H,20,24)(H2,25,26,27)/t9-,10+,11-,12+,13+,14-,15+,16+,18+/m0/s1
|
Chemical Name |
(2R,3R,4S,5R,6R)-6-((1S,2S)-2-chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2H-pyran-3-yl
dihydrogen phosphate
|
Synonyms |
Cleocin T; Clinda-Derm; Clindagel; Evoclin; U 28508; U-28508; U28508
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
H2O : 100 mg/mL (198.04 mM)
|
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: 50 mg/mL (99.02 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
 (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 1.9804 mL | 9.9020 mL | 19.8039 mL | |
5 mM | 0.3961 mL | 1.9804 mL | 3.9608 mL | |
10 mM | 0.1980 mL | 0.9902 mL | 1.9804 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.